Florence M Hoffman

Title: Florence M Hoffman: Innovator in Brain Cancer Treatment

Introduction

Florence M Hoffman is a notable inventor based in Venice, CA (US). She has made significant contributions to the field of pharmaceuticals, particularly in the treatment of brain cancer. Her innovative work has led to the development of a unique therapeutic approach that addresses a critical medical need.

Latest Patents

Hoffman holds 1 patent for her invention titled "MAO inhibitors and their conjugates as therapeutics for the treatment of brain cancer." This patent describes a pharmaceutical composition and method for treating brain cancer. The method involves administering an effective amount of compounds such as moclobemide, clorgyline, clorgyline's Near-infra-red dye Monoamine Oxidase Inhibitor (NMI), and MHI 148-clorgyline, along with their salts. This composition is particularly effective in reducing the size of glioblastomas that are resistant to temozolomide (TMZ).

Career Highlights

Hoffman is affiliated with the University of Southern California, where she continues her research and development efforts. Her work has garnered attention for its potential to improve treatment outcomes for patients suffering from brain cancer.

Collaborations

Hoffman has collaborated with esteemed colleagues such as Jean C Shih and Thomas C Chen. These partnerships have enhanced her research and contributed to the advancement of therapeutic strategies in oncology.

Conclusion

Florence M Hoffman is a pioneering inventor whose work in brain cancer treatment exemplifies the impact of innovative research in medicine. Her contributions are paving the way for new therapeutic options that could significantly benefit patients in need.